Welcome to our dedicated page for HEALTHSTREAM SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HEALTHSTREAM's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HEALTHSTREAM's regulatory disclosures and financial reporting.
HealthStream, Inc. reported strong growth for the first quarter of 2026 and reaffirmed its full-year 2026 outlook. Revenue rose to $81.2 million, up 10.5% from $73.5 million a year earlier, driven by higher subscription and professional services revenues, including contributions from the 2025 Virsys12 and MissionCare Collective acquisitions.
Operating income increased to $7.5 million, up 71.6%, while net income grew to $5.9 million and diluted EPS reached $0.20, compared with $0.14 in the prior-year quarter. Adjusted EBITDA climbed 24.1% to $20.1 million. The company ended March 31, 2026 with $66.5 million in cash, cash equivalents, and marketable securities and no debt.
HealthStream returned capital through share repurchases and dividends, buying back 342,345 shares for $7.5 million at an average price of $21.91 during the quarter and declaring a quarterly dividend of $0.035 per share, payable May 29, 2026. The board also authorized a new $10.0 million repurchase program and the company reaffirmed 2026 guidance for revenue of $323–$330 million, net income of $20.4–$22.8 million, adjusted EBITDA of $73–$77 million, and capital expenditures of $31–$34 million. Additionally, HealthStream promoted Michael M. Collier to Chief Operating Officer & Executive Vice President.
HealthStream, Inc. calls a fully virtual 2026 annual meeting for May 28, 2026 at 2:00 p.m. Central, where holders of 29,421,632 common shares as of March 30, 2026 may vote online.
Shareholders will elect three Class II directors, ratify Ernst & Young LLP as auditor for 2026, and cast an advisory vote on executive pay. The proxy details a classified nine‑member board, independent audit, compensation, and nominating committees, director and executive biographies, ESG and risk-oversight practices, and a clawback, insider trading, and anti‑hedging framework. It also outlines director cash retainers and RSU grants and explains how performance-based RSUs and special option/RSU awards link named executive officer compensation to adjusted EBITDA and other financial goals.
HealthStream Executive Vice President Trisha L. Coady exercised restricted share units that vested into 5,672 shares of common stock on March 30, 2026. These awards vested at no exercise price as part of multi-year RSU compensation grants.
To cover tax obligations on the vesting, 1,382 shares of common stock were withheld at $21.25 per share. After these routine compensation and tax-withholding transactions, Coady directly holds 39,495 shares of HealthStream common stock. The underlying RSUs follow four-year vesting schedules tied to continued service and, for some awards, achievement of performance criteria set by the Compensation Committee.
HealthStream Executive Vice President Michael Manning Collier reported several compensation-related equity transactions tied to restricted share units (RSUs). On March 30, 2026, RSUs vested and were converted into a total of 7,285 shares of common stock, consistent with the footnote stating shares were acquired on vesting of RSUs.
To cover tax obligations, 1,774 shares of common stock were withheld at a price of $21.25 per share, described as payment of tax liability by delivering securities. After these transactions, Collier directly holds 60,293 shares of HealthStream common stock. Footnotes explain that each RSU represents the right to receive one share upon vesting and outline multi-year vesting schedules, including time-based and performance-based awards contingent on continued service and achievement of specified performance criteria.
HEALTHSTREAM INC CFO and SVP Scott Alexander Roberts reported routine equity compensation activity involving restricted share units (RSUs). On March 30, 2026, multiple RSU awards were exercised into a total of 5,601 shares of common stock at a conversion price of $0.00 per share, reflecting vesting of prior grants.
The filing shows 1,364 common shares were disposed of at $21.25 per share to cover tax liabilities tied to these vestings, with no open‑market sales. After these transactions, Roberts directly owned 36,800 shares of common stock. Footnotes explain that each RSU converts into one share and that the awards vest over multi‑year schedules, some contingent on performance criteria.
HealthStream Executive Vice President Kevin P. O'Hara reported routine equity compensation activity. On March 30, 2026, multiple batches of restricted share units vested and were converted into a total of 5,672 shares of common stock at a stated exercise price of $0.00 per share.
To cover related tax obligations, 1,382 common shares were disposed of through a tax-withholding transaction at $21.25 per share, rather than through an open-market sale. After these transactions, O'Hara directly holds 23,982 shares of HealthStream common stock. The filing shows no remaining derivative positions tied to these restricted share units.
HealthStream Senior Vice President Michael Scott McQuigg reported routine equity compensation activity involving restricted share units (RSUs) that vested into common stock. On March 30, 2026, he exercised RSUs that delivered 5,601 shares of HealthStream common stock at a conversion price of $0.00 per share.
As part of the same event, 1,364 shares of common stock were withheld at $21.25 per share to cover tax obligations, a non‑market disposition. Following these transactions, he directly owned 35,191 shares of HealthStream common stock. Footnotes explain that each RSU converts into one share upon vesting and that awards follow multi‑year vesting schedules tied to continued service and, for certain grants, performance criteria.
HealthStream Inc Senior Vice President Jennifer Hayes LoPresto exercised restricted share units into common stock and had shares withheld for taxes. On the RSU vesting date, she acquired 803 shares of common stock at a conversion price of $0.00 per share through RSU exercises. To cover tax liabilities, 274 common shares were withheld at $21.25 per share in a tax-withholding disposition, which is not an open-market sale. After these transactions, LoPresto directly holds 6,585 shares of HealthStream common stock. The RSUs vest under multi-year schedules that require continued service.
HealthStream CEO and Chairman Robert A. Frist Jr. reported routine equity compensation activity involving restricted share units (RSUs). He exercised RSUs to acquire 4,038 shares of common stock at a conversion price of $0.00 per share, reflecting vesting of previously granted awards. To cover tax obligations, 984 shares were withheld at $21.25 per share, a non-market, tax-withholding disposition. After these transactions, his directly held common stock position is 4,051,106 shares. The filing also lists multiple indirect common stock holdings through various family and children’s trusts, which are shown as holdings rather than new open-market trades. Several RSU grants remain subject to multi-year vesting schedules contingent on continued service through dates in 2026–2029.